Skip to main content
logo
Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
20.14
+0.69 (3.55%)
At close: Nov 6, 2026, 4:00 PM EST
20.40
+0.26 (1.29%)
After-hours: Nov 6, 2026, 7:30 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Net Revenue
1.90B1.75B1.69B
Specialty Net Revenue
599.75M528.51M445.75M
AvKARE Net Revenue
699.06M744.73M662.95M
Revenue (Total)
3.20B3.02B2.79B

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Gross Profit
743.59M683.92M673.90M
Specialty Gross Profit
399.02M282.59M242.93M
AvKARE Gross Profit
143.31M146.79M103.61M
Gross Profit (Total)
1.29B1.11B1.02B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Operating Income
418.05M380.80M270.10M
Specialty Operating Income
221.91M116.00M113.58M
AvKARE Operating Income
74.63M83.62M42.90M
Corporate and Other Operating Income
-235.60M-186.32M-177.26M
Operating Income (Total)
478.99M394.10M249.33M